Short Interest in Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Decreases By 6.3%

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) was the target of a large decline in short interest in September. As of September 30th, there was short interest totalling 3,000 shares, a decline of 6.3% from the September 15th total of 3,200 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 30.0 days.

Kissei Pharmaceutical Stock Performance

OTCMKTS KSPHF opened at $25.00 on Friday. The company’s 50 day simple moving average is $22.39 and its 200 day simple moving average is $21.67. Kissei Pharmaceutical has a 12 month low of $19.32 and a 12 month high of $25.00.

Kissei Pharmaceutical Company Profile

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.